Lupin receives approval from USFDA for Tenofovir Alafenamide tablets

Lupin receives approval from USFDA for Tenofovir Alafenamide tablets

This product will be manufactured at Lupin’s Nagpur facility in India

FPJ Web DeskUpdated: Friday, March 31, 2023, 01:07 PM IST
article-image
Lupin receives approval from USFDA for Tenofovir Alafenamide tablets | Image: Lupin (Representative)

Lupin Limited today announced that it has received approval from the United States Food and Drug Administration (U.S.FDA) for its abbreviated New Drug Application for Tenofovir Alafenamide tablets, 25 mg, via an exchange filing.

It is the generic equivalent of Vemlidy Tablets, 25 mg, of Gilead Sciences, Inc.

This product will be manufactured at Lupin’s Nagpur facility in India.

RECENT STORIES

Ecos (India) Mobility Submits Draft Paper To SEBI For IPO Fundraising

Ecos (India) Mobility Submits Draft Paper To SEBI For IPO Fundraising

How Data Is Enabling Innovation In Biomedical Devices For Healthier Lives

How Data Is Enabling Innovation In Biomedical Devices For Healthier Lives

Heralding Mediated Dispute Resolution Over Litigation: The Mediation Act, 2023, Future Of Indian...

Heralding Mediated Dispute Resolution Over Litigation: The Mediation Act, 2023, Future Of Indian...

Force Motors Shifts Gears: Exiting Tractors And Connected Activity Business At The End Of FY24

Force Motors Shifts Gears: Exiting Tractors And Connected Activity Business At The End Of FY24

'From Shop Floor To Success': Anand Mahindra Backs Elon Musk's Call For Recognition Of Manufacturing...

'From Shop Floor To Success': Anand Mahindra Backs Elon Musk's Call For Recognition Of Manufacturing...